Viewing Study NCT03359018


Ignite Creation Date: 2025-12-25 @ 4:30 AM
Ignite Modification Date: 2026-01-17 @ 3:07 AM
Study NCT ID: NCT03359018
Status: COMPLETED
Last Update Posted: 2020-05-19
First Post: 2017-11-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Apatinib Plus Anti-PD1 Therapy for Advanced Osteosarcoma
Sponsor: Peking University People's Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Progression-free Survival View
None Overall Survival View
None Clinical Benefit Rate View
None Toxicity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None osteosarcoma View
None advanced View
None apatinib View
None PD-1 View